Inventor
GOLLOB JARED
US12 patents
⚠️ This page may combine multiple inventors who share the name “GOLLOB JARED”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALNYLAM PHARMACEUTICALS INC
7 patentsUS10246708B2Apr 2, 2019
Dosages and methods for delivering lipid formulated nucleic acid molecules
ALNYLAM PHARMACEUTICALS INC16 citations88
US12031133B2Jul 9, 2024
GNAQ targeted dsRNA compositions and methods for inhibiting expression
ALNYLAM PHARMACEUTICALS INC0 citations62
US10954516B2Mar 23, 2021
GNAQ targeted dsRNA compositions and methods for inhibiting expression
ALNYLAM PHARMACEUTICALS INC0 citations62
US9963700B2May 8, 2018
GNAQ targeted dsRNA compositions and methods for inhibiting expression
ALNYLAM PHARMACEUTICALS INC1 citations62
US11806360B2Nov 7, 2023
Compositions and methods for treating transthyretin (TTR) mediated amyloidosis
ALNYLAM PHARMACEUTICALS INC1 citations61
US11827883B2Nov 28, 2023
Dosages and methods for delivering lipid formulated nucleic acid molecules
ALNYLAM PHARMACEUTICALS INC0 citations57
US9566295B2Feb 14, 2017
GNAQ targeted dsRNA compositions and methods for inhibiting expression
ALNYLAM PHARMACEUTICALS INC0 citations51
GOLLOB JARED
3 patentsUS8324368B2Dec 4, 2012
GNAQ targeted dsRNA compositions and methods for inhibiting expression
GOLLOB JARED12 citations91
US8889644B2Nov 18, 2014
GNAQ targeted dsRNA compositions and methods for inhibiting expression
GOLLOB JARED5 citations80
US9339513B2May 17, 2016
Lipid formulated compositions and methods for inhibiting expression of Eg5 and VEGF genes
GOLLOB JARED4 citations67